Chao Zheng is a Director in CMC (Chemistry, Manufacturing, and Controls) Development at Boehringer Ingelheim with over a decade of experience across pharmaceutical R&D, spanning drug discovery, development, project leadership, strategy, and operations.
In addition to his industry role, Chao is an active angel investor, startup mentor, and advocate for life science innovation. He works with early-stage companies across therapeutics, medical devices, and digital health, helping founders navigate scientific and development challenges as they translate promising research into products that improve patient outcomes.
Chao is particularly interested in helping scientists and entrepreneurs bridge the gap between discovery and impact. He holds a PhD in Biochemistry and Structural Biology from Weill Cornell Medical College and completed postdoctoral research at Pfizer.